{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:28:25Z","timestamp":1794000505278,"version":"4.8.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC113-2314-B-075-007 -"],"award-info":[{"award-number":["NSTC113-2314-B-075-007 -"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004699","name":"Chung Shan Medical University Hospital","doi-asserted-by":"publisher","award":["CSH-2022 -A-023"],"award-info":[{"award-number":["CSH-2022 -A-023"]}],"id":[{"id":"10.13039\/501100004699","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V113C-166"],"award-info":[{"award-number":["V113C-166"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V114C-177"],"award-info":[{"award-number":["V114C-177"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.metabol.2026.156790","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:59:46Z","timestamp":1790693986000},"page":"156790","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Comparative outcomes of GLP-1 receptor agonist and SGLT2 inhibitor users after liver transplantation: An emulated target trial"],"prefix":"10.1016","volume":"185","author":[{"given":"Fu-Shun","family":"Yen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Lun","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Min","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Cheng","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8768-8500","authenticated-orcid":false,"given":"Chin-Su","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Chih","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chii-Min","family":"Hwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Cheng-Chung","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.metabol.2026.156790_bb0005","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s13300-018-0374-8","article-title":"Post-liver transplantation diabetes mellitus: a review of relevance and approach to treatment","volume":"9","author":"Pel\u00e1ez-Jaramillo","year":"2018","journal-title":"Diabetes Ther"},{"issue":"6","key":"10.1016\/j.metabol.2026.156790_bb0010","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.jceh.2022.03.012","article-title":"Long-term care of the adult liver transplant recipient","volume":"12","author":"Neuberger","year":"2022","journal-title":"J Clin Exp Hepatol"},{"issue":"12","key":"10.1016\/j.metabol.2026.156790_bb0015","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/tri.13358","article-title":"2018 annual report of the European Liver Transplant Registry (ELTR) - 50-year evolution of liver transplantation","volume":"31","author":"Adam","year":"2018","journal-title":"Transpl Int"},{"key":"10.1016\/j.metabol.2026.156790_bb0020","series-title":"Transplants by organ type","author":"United Network for Organ Sharing","year":"2025"},{"issue":"8","key":"10.1016\/j.metabol.2026.156790_bb0025","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1111\/liv.12779","article-title":"The outcomes of adult liver transplants in the United States from 1987 to 2013","volume":"35","author":"Stepanova","year":"2015","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.metabol.2026.156790_bb0030","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.dld.2019.07.007","article-title":"High prevalence of early atherosclerotic and cardiac damage in patients undergoing liver transplantation: preliminary results","volume":"52","author":"Pisano","year":"2020","journal-title":"Dig Liver Dis"},{"issue":"6","key":"10.1016\/j.metabol.2026.156790_bb0035","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13554","article-title":"The impact of post-transplant diabetes mellitus on liver transplant outcomes","volume":"33","author":"Lieber","year":"2019","journal-title":"Clin Transplant"},{"issue":"1","key":"10.1016\/j.metabol.2026.156790_bb0040","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/ckj\/sfab131","article-title":"Management of post-transplant diabetes mellitus: an opportunity for novel therapeutics","volume":"15","author":"Montero","year":"2021","journal-title":"Clin Kidney J"},{"issue":"3","key":"10.1016\/j.metabol.2026.156790_bb0045","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/ndt\/gfad258","article-title":"International consensus on post-transplantation diabetes mellitus","volume":"39","author":"Sharif","year":"2024","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.metabol.2026.156790_bb0050","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/hep4.1876","article-title":"Personalizing diabetes management in liver transplant recipients: the new era for optimizing risk management","volume":"6","author":"Richardson","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.metabol.2026.156790_bb0055","article-title":"Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials","author":"Badve","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10166","key":"10.1016\/j.metabol.2026.156790_bb0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(18)32590-X","article-title":"SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"393","author":"Zelniker","year":"2019","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.metabol.2026.156790_bb0065","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","article-title":"A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis","volume":"384","author":"Newsome","year":"2021","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.metabol.2026.156790_bb0070","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1053\/j.gastro.2008.06.047","article-title":"Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis","volume":"135","author":"Aithal","year":"2008","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.metabol.2026.156790_bb0075","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2337\/dc15-2383","article-title":"GLP-1 restores altered insulin and glucagon secretion in posttransplantation diabetes","volume":"39","author":"Halden","year":"2016","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.metabol.2026.156790_bb0080","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1111\/dom.15769","article-title":"Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors for the treatment of diabetes mellitus in liver transplant recipients","volume":"26","author":"Zheng","year":"2024","journal-title":"Diabetes Obes Metab"},{"issue":"12","key":"10.1016\/j.metabol.2026.156790_bb0085","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1001\/jama.2025.13350","article-title":"Transparent reporting of observational studies emulating a target trial-the TARGET statement","volume":"334","author":"Cashin","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2026.156790_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajt.2025.03.019","article-title":"The impact of sodium-glucose cotransporter-2 inhibitors on dialysis risk and mortality in kidney transplant patients with diabetes","author":"Yen","year":"2025","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.metabol.2026.156790_bb0095","doi-asserted-by":"crossref","DOI":"10.1093\/jamiaopen\/ooad035","article-title":"A global federated real-world data and analytics platform for research","volume":"6","author":"Palchuk","year":"2023","journal-title":"JAMIA Open"},{"issue":"2","key":"10.1016\/j.metabol.2026.156790_bb0100","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jss.2007.02.019","article-title":"Effect of intraoperative hyperglycemia during liver transplantation","volume":"140","author":"Ammori","year":"2007","journal-title":"J Surg Res"},{"issue":"4","key":"10.1016\/j.metabol.2026.156790_bb0105","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/dom.13619","article-title":"Largest single-centre experience of dulaglutide for management of diabetes mellitus in solid organ transplant recipients","volume":"21","author":"Singh","year":"2019","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"10.1016\/j.metabol.2026.156790_bb0110","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/joim.20077","article-title":"Effects of SGLT2 inhibitors on transplant survival and key clinical outcomes in heart transplant recipients with diabetes","volume":"297","author":"Yen","year":"2025","journal-title":"J Intern Med"},{"issue":"5","key":"10.1016\/j.metabol.2026.156790_bb0115","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1002\/hep.31595","article-title":"Pharmacotherapy for weight loss in cirrhosis and liver transplantation: translating the data and underused potential","volume":"73","author":"Brown","year":"2021","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.metabol.2026.156790_bb0120","first-page":"17","article-title":"Pharmacologic management of obesity after liver transplantation: a critical review","volume":"6","author":"Zahrawi","year":"2023","journal-title":"Ann Gastroenterol Dig Disord"},{"issue":"21","key":"10.1016\/j.metabol.2026.156790_bb0125","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.3748\/wjg.v26.i21.2740","article-title":"Post-transplant diabetes mellitus and preexisting liver disease - a bidirectional relationship affecting treatment and management","volume":"26","author":"Cigrovski Berkovic","year":"2020","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.metabol.2026.156790_bb0130","article-title":"NAFLD and liver transplantation: disease burden, current management and future challenges","volume":"2","author":"Burra","year":"2020","journal-title":"JHEP Rep"},{"issue":"1","key":"10.1016\/j.metabol.2026.156790_bb0135","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-025-02649-0","article-title":"Association of glucagon-like peptide-1 receptor agonists with cardiovascular and kidney outcomes in type 2 diabetic kidney transplant recipients","volume":"24","author":"Lin","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.metabol.2026.156790_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.721135","article-title":"GLP-1 receptor agonists: beyond their pancreatic effects","volume":"12","author":"Zhao","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"10.1016\/j.metabol.2026.156790_bb0145","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41569-023-00849-3","article-title":"Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action","volume":"20","author":"Ussher","year":"2023","journal-title":"Nat Rev Cardiol"},{"issue":"7","key":"10.1016\/j.metabol.2026.156790_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26073050","article-title":"GLP-1 receptor agonists and myocardial perfusion: bridging mechanisms to clinical outcomes","volume":"26","author":"Karakasis","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.metabol.2026.156790_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2025.103149","article-title":"SGLT2 inhibitors and cardiac fibrosis: a comprehensive review","volume":"50","author":"Karakasis","year":"2025","journal-title":"Curr Probl Cardiol"},{"issue":"7","key":"10.1016\/j.metabol.2026.156790_bb0160","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41569-023-00849-3","article-title":"Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action","volume":"20","author":"Ussher","year":"2023","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"10.1016\/j.metabol.2026.156790_bb0165","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jcjd.2019.09.003","article-title":"Mechanisms by which glucagon-like-peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors reduce cardiovascular risk in adults with type 2 diabetes mellitus","volume":"44","author":"Sharma","year":"2020","journal-title":"Can J Diabetes"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049526003033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049526003033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:04:30Z","timestamp":1793999070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049526003033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":33,"alternative-id":["S0026049526003033"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2026.156790","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative outcomes of GLP-1 receptor agonist and SGLT2 inhibitor users after liver transplantation: An emulated target trial","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2026.156790","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156790"}}